A Korean biobank highlights the significance of preserving live parasite samples globally and how certain species support human health and ecosystems.
We are in an era of groundbreaking scientific discoveries, unveiling deeper insights into the fundamental elements of life—DNA, RNA, and proteins. These advancements are transforming lives, revolutionizing treatments for cancer, tuberculosis, and genetic disorders, accelerating drug discovery, and enhancing public health. At Probgen, we celebrate the researchers and innovators who are tackling these challenges, unlocking new possibilities, and driving medical breakthroughs. Their dedication is shaping the future of healthcare. Explore an inspiring collection of customer stories and videos showcasing their pioneering work and the impact of their discoveries below.
GNOMIX developed flexible tests for viral load, gene copy number variation, and more, unlocking endless applications with dPCR.
Antiretroviral therapy (ART) has enabled millions to live well with HIV, yet the disease still strains healthcare systems, and social stigma persists.
A Korean biobank highlights the significance of preserving live parasite samples globally and how certain species support human health and ecosystems.
Chagas disease is spreading in North America, becoming a major health concern in underserved communities. However, healthcare researchers have developed a strategy to address it.
A key innovation from the pandemic is wastewater-based epidemiology (WBE), and public health experts are eager about its potential to identify various pathogen-related infections in the future.
Early-warning monitoring is essential for aiding authorities in combating COVID-19 and preparing for future outbreaks. Wastewater testing plays a crucial role in this effort.
Clinical researchers are urgently seeking medical breakthroughs. BioXpedia, a supporting lab, utilizes digital PCR technology, specifically the QIAcuity, to provide precise data from the distinct samples they receive.
The rise of gene doping as a performance-enhancing method for athletes and how PCR techniques can be used to detect it.
A microbiology lab developed from scratch using Probgen PCR technology to guarantee accurate results, cell line detection, and contamination-free samples.
I.A.G.E. uses digital PCR (QIAcuity) to analyze wastewater samples for COVID-19, track outbreaks, and detect specific sequences related to SARS-CoV-2 mutations.
Digital PCR technology precisely quantifies the copy numbers of a single gene, helping to explain why some individuals are more susceptible to obesity.
Doctor utilizing digital PCR to tackle a major challenge in diagnostics: achieving global test standardization.
A rare respiratory infection in São Paulo highlights the importance of molecular diagnostic tests in delivering quick and precise treatment.
An interview with public health expert Julie Vaishampayan on emerging viral threats like avian influenza.
The rare case of a camper returning with both a parasitic and bacterial co-infection, highlighting how molecular testing can enhance these diagnoses.
What do a surf camp for children with special needs and infectious diseases have in common? Not much, except for a dedicated pediatrician driven by a passion for social causes.
When the COVID-19 pandemic began, Michigan’s first lab to conduct PCR tests handled around 90 samples daily. By the time Omicron emerged, it was processing 2,700. How did they manage to meet the growing demand for testing, especially during the nationwide shortage of testing kits?
It’s remarkable to consider how a virus, incapable of completing its own life cycle, can cause such widespread damage. The real challenge is how labs can keep up with the countless pathogens out there.
With the evolving nature of the pandemic and the availability of promising COVID-19 treatments, determining the right time and method for using various tests has become challenging. How are labs choosing which tests to use, and why is ongoing testing crucial?
How can you guarantee passenger safety on a confined ship, particularly with thousands onboard? Costa Cruises has developed a solution.
In response to the COVID-19 pandemic, Great Lakes Labs President and CEO Michelle Volk shifted the lab’s focus from forensics to clinical medicine, offering the community quick, reliable testing and reassurance.
The Mako Medical team provides rapid test results to vulnerable senior communities, understanding that delays can pose significant challenges for patients with limited time for diagnoses.
The new QIAstat-Dx syndromic testing device is reducing costs and saving time in emergency rooms.
The Geneva-based non-profit FIND tackles poverty-related diseases by using collaborative methods to combat emerging epidemic threats.
Copyright © 2025 https://probgenbiotech.com/ All Rights Reserved.